Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gator SCALES-WHF: Lasix ONYU for Worsening Heart Failure
NCT06979726Phase 4Recruiting
- Sponsor
- University of Florida
- Start
- Nov 2025
- Primary completion
- Nov 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of furosemide in heart failure (HF) and Volume overload, sponsored by University of Florida. Primary endpoint: Safety of Lasix ONYU Use at 30 days. Started Nov 2025; status: recruiting.
02
Drugs
furosemide
03
Conditions
heart failure (HF)Volume overload
Beyond the preview
Go deeper on NCT06979726.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06979726.